California AB432 mandates health insurers to cover perimenopause and menopause treatments without discrimination or utilization management.

California AB432 requires health insurers to cover evaluation and treatment options for perimenopause and menopause symptoms without discrimination based on gender expression or identity. The bill mandates coverage for various formulations and methods of administration, including oral, topical, vaginal, rectal, subcutaneous, injectable, or intravenous routes. It also requires coverage for at least one outpatient prescription drug from each class of medications approved to prevent and treat osteoporosis.

California AB432 mandates health insurers to cover perimenopause and menopause treatments without discrimination or utilization management.

California AB432 requires health insurers to cover evaluation and treatment options for perimenopause and menopause symptoms without discrimination based on gender expression or identity. The bill mandates coverage for various formulations and methods of administration, including oral, topical, vaginal, rectal, subcutaneous, injectable, or intravenous routes. It also requires coverage for at least one outpatient prescription drug from each class of medications approved to prevent and treat osteoporosis.